Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
602s Biochemical Society Transactions ( 1 996) 24 H37 CHARACTERISATION OF THE BCL-2 INTERACTING PROTEIN, R-RAS. Alex Eccleston, Maria Jose Fernandez-Sarabia and Frank McCormick. Onyx Pharmaceuticals, 303 1 Research Drive, Richmond, CA 94806, USA. Bcl-2 is a key regulator of apoptosis, but its mechanism of action remains unknown. Using Bcl-2 as the bait in a two-hybrid screen, R-ras was isolated and this interaction was confirmed in vivo. R-ras is a member of the ras family of GTP binding proteins and shares an identical core effector domain with H-ras. We have shown that the interaction between Bcl-2 and R-ras is specific since an interaction was not observed between Bcl-2 and either H-ras, or TCZl/R-rasE. Although R-ras has been shown t o interact in vitro with some of the same effector molecules as H-ras, i t appears that R-ras has a different biological role t o H-ras. For example, whilst oncogenic H-ras can transform rat-1 cells, activated R-ras (V38) cannot. To investigate if R-ras can activate the same signalling pathways as H-ras, we used activation of the MAP kinase cascade in cos cells as a read-out. Whilst H-ras efficiently activates c-Raf and the MAP kinase, Erk-2, R-ras does not. R-ras is localised t o the plasma membrane in these cells, as is H-ras, but appears less efficient than H-ras in translocating c-Raf there. Chimaeras between H-ras and R-ras have been made and their kinase activity is being tested t o distinguish which structural features of R-ras determine its differential behaviour t o H-ras. These chimaeras are also being tested in an IL-3 dependent B cell line, t o elucidate the mechanism of the previously observed effect of R-ras in suppressing Bcl-2 action in these cells. H39 EXPRESSION OF APOPTOSIS-MODULATINGGENES IN HUMAN MULTIDRUG RESISTANT CELL LINES L Connolly, R NicAmhlaoibh, S Verhaegen, and M Clynes. National Cell and Tissue Culture Centre, Dublin City University, Dublin, Eire. The expression of apoptosis-modulating genes was investigated in sensitive and multidrug resistant variants of two human cell models, the lung carcinoma cell line DLKP (1) and the myelomonocytic cell line HL60, the latter a well studied model for apoptosis (2). In all of the cell lines tested mRNA for the bcl-2, bcl-xL, bcl-a, and bax genes could be detected using RT-PCR. Large differences between the sensitive and resistant variant were not apparent, except in the case of the apoptosis-suppressinggene bcl-xL, which was increased 2 to 3-fold in the resistant variant, DLKP-A. Bcl-2 and bax were also examined at the protein level using Westem blot. Bcl-2 protein was not detected in DLKP or its variant, but was present in both the sensitive HL-60s and the multidrug resistant variant HL-6OADR. The apoptosis-promoting gene, bax was expressed in all the DLKP-variants, and in HL-GOS, but was absent in HL-GOADR. From time-lapse videomicroscopy observations we know that an apoptotic pathway is intrinsically available in both the sensitive parental line, DLKP and the P-glycoprotein expressing variant, DLKP-A. Similarly, morphological analysis of both HL-60s and the MRP expressing variant HL-6OADR show the intrinsic capability of cell death via apoptosis when treated with a wide variety of anti-cancer drugs. These results indicate that, in addition to overexpressing protein involved in drug efflux (e.g. P-glycoprotein or MRP). rnultidrug resistant cells may show altered expression of proteins which determine sensitivity of the cell to drug-induced apoptosis. Clynes M, Redmond A, Moran E, and Gilvany U. Multiple (1) Drug-resistance in a variant of non-small cell lung carcinoma cell line, DLKP-A. Cytotechnology. 70: 75-89 (1992). (2) Cotter TG, Femandes RS, Verhaegen S, and McCarthy JV. Cell death in the myeloid lineage. Immunol. Rev., 142: 93-112 (1994). H40 A RADIATION RESISTANT NEUROBLASTOMA H38 INCREASED LEVELS OF BCL-XLEXPRESSION CORRELATE WITH RESCUE FROM APOPTOSIS IN THE BURKITTS-LYMPHOMA CELL LINE RAMOS. and Kirstine b o x , Department o f Biochemistry, University o f Oxford, South Parks Rd, Oxford, OX1 3QU. Introduction: Selection via inhibition o f a default apoptotic pathway plays a central role during development o f the immune response. One such selection pathway occurs in the germinal centre (GC) during B cell affinity maturation. The Ramos-BL B cell line originates from transformation o f GC B cells and thus retains a vestige o f GC selection: apoptosis induced by ligation o f surface immunoglogulin (sIgM) can be rescued by signals through CD40. In GC cells rescue i s mediated, in part, by Bcl-2 up-regulation. Aim: The potential role o f Bcl-2 and its related proteins Bax and Bcl-x, were investigated during induction and suppression o f apoptosis in Ramos-BL B cells. Results: Bcl-x, was found to be expressed as a doublet o f 29 kDa and 31 kDa: the 31 kDa isoform localises to the cytosol whereas the 29 kDa form i s membrane-bound. Rescue signals were shown to be accompanied by an increase in the expression o f both Bcl-2, by 48h, and Bcl-xL-p29, by 12h post-treatment. Levels o f Bcl-xLp3 1 and Bax were unchanged. Conclusion: Our results indicate that CD40-induced survival may be initially mediated by Bclx,-p29 and only later by Bcl-2. This suggests a role for Bcl-x,p29 in offering transient protection from apoptosis in GC cells undergoing selection. SUBLINE DISPLAYS REDUCED APOPTOSIS AND REDUCED LEVELS OF BCL 2 James Russell, The Johns Hopkins Oncology Center, 600 N Wolfe St, Baltimore, MD 2 1287 USA A population of radiosensitive human neuroblastoma IMR32 cells was exposed to repeated doses of 2 Gy X-irradiation, resulting in the emergence after 15 such fractions of a more resistant population. The fraction of cells surviving a dose of 2 Gy was 0.05 for the parental cells as opposed to 0.19 for the resistant cells. Although these cells were unstable and tended to revert to a parental phenotype, it was possible to clone out cells which maintained the resistant phenotype over 35 passages. The resistant and parental cells did not differ in their ability to rejoin radiation-induceddouble strand breaks, and both lines displayed similar levels of chromosome damage, as judged by micronucleus frequency &r radiation. However, the resistant cells showed significantly less apoptosis following irradiation, implying that the reduced susceptibility to radiation-inducedapoptosis was responsible for the enhanced clonogenic survival. The molecular basis for these differences is being pursued. The cells do not differ in their p53 status, which i s wild-type in both lines. With regard to the Bcl-2 family, the results are paradoxical. Bcl-2 i s more highly expressed in parental cells than in the resistant line. In neither line does expression change following mhation. Constitutive levels of Bax are approximately the same in both cell lines, though the Bax protein level falls after radiation exposure, but only in the parental cells. Bcl. expression i s similar in parental and resistant cells. Bcl. i s not expressed in either line. The results suggest that other molecules are duencing apoptosis in these cells.